#psychedelic-clinical-trial

#psychedelic-clinical-trial

The Supreme Court of the United States held that Colorado's statutory ban on conversion therapy was 'likely unconstitutional.' Conversion therapy refers to interventions intended to change or suppress an individual's sexual orientation or gender identity, typically by promoting heterosexuality or cisgender identity and associated behaviors as the desired outcome.

The inquest concluded that Robinson's prescription for medicinal cannabis had probably contributed to his death, with the coroner stating that it acted as an obstacle to appropriate care.

Many situations contain irreducible uncertainty. No matter how many variables we try to control, we can't reduce uncertainty to zero. It's inherent in the messiness of life.

There is a unique kind of pain in losing your mind, not just once, but over and over. Losing your perception of reality, of your emotions, of your closest relationships-both across months and multiple times a day. Knowing deep down that something is wrong but being unable to stop it.

At a Friday hearing in California, US District Judge Yvonne Gonzalez Rogers said that Musk's use of ketamine will be off limits to OpenAI's legal team and its CEO Sam Altman as the case is set to go to trial next month, Bloomberg reports, which will likely save Musk from heaps of further embarrassment.

The condition, called recessive RNU2-2-related neurodevelopmental disorder, is associated with seizures and severe developmental delay in children less than a year-old, in areas such as speech and walking.

We found no evidence any form of cannabis is effective in treating anxiety, depression or post-traumatic stress disorder, which are three of the leading reasons for which cannabis is prescribed. The cannabis medications being administered in these studies were largely oral formulations, such as capsules, sprays or oils. In real life, people typically use smoked cannabis, and there is even less evidence of its effectiveness for mental health.

Some clinicians have an uncanny quality. A colleague describes herself and others with this instinct as "witchy"-a capacity to know things about patients they haven't said yet, to follow a stray association to a song lyric or a half-remembered cultural reference and arrive, reliably, at something the patient urgently needed to say but couldn't reach on their own. We see with artificial intelligence these intriguing possibilities for discovery, especially as connections that human beings never would see pop out of apparently unrelated data.

Depression is insidious. For people suffering from depression, joy is elusive. Depression is not only a general feeling of sadness or being down and out. It is a serious condition and needs attention. People suffering from depression cannot just get over it and move on. They need support, healing, and to discover the epicenter of their pain.

Evidence Based Medicine was formalized in the 1990s, largely by Canadian physician David Sackett. Sackett described the goal of EBM is to replace hunches and habits with data and clinical trials. Clinical guidelines were developed involving protocols that tell doctors which drug to prescribe first, what dose to use, when to escalate treatment, and when to refer a patient to a specialist.

EMDR is a well-established, evidence-based therapy primarily used to help individuals process traumatic or distressing experiences. Traditionally delivered in a face-to-face setting, EMDR works by helping the brain reprocess memories that have become "stuck", reducing their emotional intensity over time. It has been widely recognised for its effectiveness in treating post-traumatic stress disorder (PTSD), anxiety, phobias and other trauma-related conditions.

The standard explanation is that ketamine blocks NMDA receptors. These receptors bind glutamate, which is a chemical messenger found throughout the brain and body. By blocking NMDA receptors, ketamine increase "brain-derived neurotrophic factor" (BDNF), a protein which I refer to as "Miracle-Grow for the brain." BDNF promotes neuroplasticity-which is the growth of new connections (synapses) in the brain. This has traditionally been viewed as the primary mechanism responsible for ketamine's therapeutic benefits. But ketamine does so much more!

Statistics show that about one-third of people with depression achieve remission-meaning their symptoms are gone-with traditional antidepressant medications. This matched my experience treating people, and I had grown to accept that this was as good as it gets. Although I wasn't thrilled with the fact that many people continued to struggle with significant symptoms of persistent depression, it seemed this was as good as we could do.

Yes, there has been a shocking lack of progress in developing transformative psychiatric medicine (We need new drugs for mental ill-health, 5 February), but this may be because in mental health, drugs are not always the answer (see, for example, Richard P Bentall's Doctoring the Mind). Huge progress has been made in the effectiveness of talking therapies for example, free effective treatment for post-traumatic stress disorder (PTSD) is available to all UK army veterans through the charity PTSD Resolution.

Every day, many thousands of parents across the U.S. face the difficult question of whether to place their child or teenager on a psychotropic medication. Receiving a diagnosis of a mental disorder can be scary and confusing, for the youth as well as their parents/caretakers. What is ADHD? Depression? Anxiety? OCD? Bipolar? What are the available treatments? Do we have to use medications to treat the symptoms?

Before treatment began, participants underwent neuroimaging. Instead of relying on a single modality, the researchers fused structural connectivity (how regions are physically wired) with functional connectivity (how regions co-activate at rest). The goal was not to throw every possible feature at a black box, but to learn a constrained pattern-what the authors call structure-function "covariation"-that carries the most predictive signal for outcome. In other words, the model tries to find the smallest set of connections that meaningfully forecasts symptom change.

Summer passed Valerie Zeko by when she was 27, as she vegged out on the couch watching TV instead of seeing friends or exploring the overcast beach near her house. She later learned that period was her first episode of depression. I felt like the fog was in my head as well as outside, said Zeko, now 57, describing the mood disorder that would squelch her happiness, motivation and self-esteem for 28 years until she finally found effective treatment.